These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 31078739)

  • 1. Niclosamide repositioning for treating cancer: Challenges and nano-based drug delivery opportunities.
    Barbosa EJ; Löbenberg R; de Araujo GLB; Bou-Chacra NA
    Eur J Pharm Biopharm; 2019 Aug; 141():58-69. PubMed ID: 31078739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and evaluation of cyclodextrin complexes for improved anticancer activity of repurposed drug: Niclosamide.
    Lodagekar A; Borkar RM; Thatikonda S; Chavan RB; Naidu VGM; Shastri NR; Srinivas R; Chella N
    Carbohydr Polym; 2019 May; 212():252-259. PubMed ID: 30832855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward Repositioning Niclosamide for Antivirulence Therapy of Pseudomonas aeruginosa Lung Infections: Development of Inhalable Formulations through Nanosuspension Technology.
    Costabile G; d'Angelo I; Rampioni G; Bondì R; Pompili B; Ascenzioni F; Mitidieri E; d'Emmanuele di Villa Bianca R; Sorrentino R; Miro A; Quaglia F; Imperi F; Leoni L; Ungaro F
    Mol Pharm; 2015 Aug; 12(8):2604-17. PubMed ID: 25974285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biotin-targeted Pluronic(®) P123/F127 mixed micelles delivering niclosamide: A repositioning strategy to treat drug-resistant lung cancer cells.
    Russo A; Pellosi DS; Pagliara V; Milone MR; Pucci B; Caetano W; Hioka N; Budillon A; Ungaro F; Russo G; Quaglia F
    Int J Pharm; 2016 Sep; 511(1):127-139. PubMed ID: 27374195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of transferrin receptors in oncology: the development of functional nano-based drug delivery systems.
    Tortorella S; Karagiannis TC
    Curr Drug Deliv; 2014; 11(4):427-43. PubMed ID: 24387131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and evaluation of injectable niclosamide nanocrystals prepared by wet media milling technique.
    Ye Y; Zhang X; Zhang T; Wang H; Wu B
    Drug Dev Ind Pharm; 2015; 41(9):1416-24. PubMed ID: 25204767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled delivery of bPEI-niclosamide complexes by PEO nanofibers and evaluation of its anti-neoplastic potentials.
    Kumar SU; Gopinath P
    Colloids Surf B Biointerfaces; 2015 Jul; 131():170-81. PubMed ID: 25988281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and in vitro antitumor effects on MDA-MB-231 cells of niclosamide nanocrystals stabilized by poloxamer188 and PBS.
    Fu Q; Jin X; Zhang Z; Lv H
    Int J Pharm; 2020 Jun; 584():119432. PubMed ID: 32442644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Existing drugs and their application in drug discovery targeting cancer stem cells.
    Lv J; Shim JS
    Arch Pharm Res; 2015 Sep; 38(9):1617-26. PubMed ID: 26152874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
    Sack U; Walther W; Scudiero D; Selby M; Kobelt D; Lemm M; Fichtner I; Schlag PM; Shoemaker RH; Stein U
    J Natl Cancer Inst; 2011 Jul; 103(13):1018-36. PubMed ID: 21685359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Niclosamide, a Drug with Many (Re)purposes.
    Kadri H; Lambourne OA; Mehellou Y
    ChemMedChem; 2018 Jun; 13(11):1088-1091. PubMed ID: 29603892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoliposomal Encapsulation Enhances
    Hatamipour M; Jaafari MR; Momtazi-Borojeni AA; Ramezani M; Sahebkar A
    Anticancer Agents Med Chem; 2019; 19(13):1618-1626. PubMed ID: 31284876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanostructured Systems in Advanced Drug Targeting for the Cancer Treatment: Recent Patents.
    Anaya-Ruiz M; Bandala C; Landeta G; Martínez-Morales P; Zumaquero-Rios JL; Sarracent-Pérez J; Pérez-Santos M
    Recent Pat Anticancer Drug Discov; 2019; 14(1):85-94. PubMed ID: 30381087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on applications of nanostructured drug delivery systems in cancer therapy: a review.
    Aberoumandi SM; Mohammadhosseini M; Abasi E; Saghati S; Nikzamir N; Akbarzadeh A; Panahi Y; Davaran S
    Artif Cells Nanomed Biotechnol; 2017 Sep; 45(6):1-11. PubMed ID: 27632797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tailoring of physicochemical properties of nanocarriers for effective anti-cancer applications.
    Chakraborty S; Dhakshinamurthy GS; Misra SK
    J Biomed Mater Res A; 2017 Oct; 105(10):2906-2928. PubMed ID: 28643475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of nanoparticles in the improvement of systemic anticancer drug delivery.
    Field LD; Nag OK; Sangtani A; Burns KE; Delehanty JB
    Ther Deliv; 2018 Jul; 9(7):527-545. PubMed ID: 29943689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Silico Oncology Drug Repositioning and Polypharmacology.
    Cheng F
    Methods Mol Biol; 2019; 1878():243-261. PubMed ID: 30378081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of niclosamide and current therapies to overcome resistance for cancer: New frontiers for an old drug.
    Ren J; Wang B; Wu Q; Wang G
    Biomed Pharmacother; 2022 Nov; 155():113789. PubMed ID: 36271567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanostructured Systems for the Organelle-specific Delivery of Anticancer Drugs.
    Joanitti GA; Ganassin R; Rodrigues MC; Figueiro Longo JP; Jiang CS; Gu J; Leal Pinto SM; Almeida Dos Santos MF; de Azevedo RB; Muehlmann LA
    Mini Rev Med Chem; 2017; 17(3):224-236. PubMed ID: 27739361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational drugs repositioning identifies inhibitors of oncogenic PI3K/AKT/P70S6K-dependent pathways among FDA-approved compounds.
    Carrella D; Manni I; Tumaini B; Dattilo R; Papaccio F; Mutarelli M; Sirci F; Amoreo CA; Mottolese M; Iezzi M; Ciolli L; Aria V; Bosotti R; Isacchi A; Loreni F; Bardelli A; Avvedimento VE; di Bernardo D; Cardone L
    Oncotarget; 2016 Sep; 7(37):58743-58758. PubMed ID: 27542212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.